Xilio Therapeutics
XLO
#9617
Rank
NZ$68.25 M
Marketcap
$1.32
Share price
-5.23%
Change (1 day)
-24.60%
Change (1 year)

Xilio Therapeutics (XLO) - Cash on Hand

Cash on Hand as of December 2024 : NZ$92.83 Million

According to Xilio Therapeutics's latest financial reports the company has NZ$92.83 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Xilio Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$98.03 M
2022-12-31NZ$0.18 B-34.61%
2021-12-31NZ$0.28 B987.51%
2020-12-31NZ$26.66 M-63.24%
2019-12-31NZ$72.52 M